Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
10.4M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2.51M
-
Shares change
-
+2.19M
-
Total reported value, excl. options
-
$58.6M
-
Value change
-
+$51M
-
Number of buys
-
14
-
Number of sells
-
-2
-
Price
-
$23.30
Significant Holders of CervoMed Inc. - Common Stock, $0.001 par value (CRVO) as of Q1 2024
21 filings reported holding CRVO - CervoMed Inc. - Common Stock, $0.001 par value as of Q1 2024.
CervoMed Inc. - Common Stock, $0.001 par value (CRVO) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.51M shares
of 10.4M outstanding shares and own 24.24% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (862K shares), ARMISTICE CAPITAL, LLC (734K shares), Ikarian Capital, LLC (237K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (199K shares), Soleus Capital Management, L.P. (127K shares), CROWN ADVISORS MANAGEMENT, INC. (100K shares), BOOTHBAY FUND MANAGEMENT, LLC (69K shares), CWM, LLC (59.1K shares), RENAISSANCE TECHNOLOGIES LLC (30.7K shares), and VANGUARD GROUP INC (27.3K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.